Monitor for the issuer's IPO filing and any subsequent Form 4 filings by OrbiMed to track changes in its stake. The large preferred share position suggests significant pre-IPO investment.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 13 $28.50entry
- T+1 · 15h ago +5.40%α +7.32% · $30.04
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
OrbiMed Advisors LLC and OrbiMed Capital GP IX LLC filed Form 3 initial beneficial ownership reports for Windward Bio Group AG, disclosing aggregate holdings of approximately 5.7 million common shares (including shares underlying preferred stock and warrants) held through OrbiMed Private Investments IX, LP. The filing is a routine initial statement of ownership with no trading activity or change in position.
Key Facts
- OrbiMed Advisors LLC and OrbiMed Capital GP IX LLC filed Form 3 as reporting persons for Windward Bio Group AG.
- OrbiMed Private Investments IX, LP holds 531,632 common shares, 3,561,936 common shares issuable upon conversion of Series A Preferred Shares, 1,611,008 common shares issuable upon conversion of Series B Preferred Shares, and warrants to purchase 216,668 common shares at $0.02 per share expiring May 12, 2036.
- Total common share equivalent position is approximately 5,921,244 shares.
- Series A and B Preferred Shares convert 1:1 into common shares immediately prior to the issuer's IPO closing.
- David P. Bonita, a member of OrbiMed Advisors, serves on the issuer's board of directors.
- The reporting persons disclaim beneficial ownership except for pecuniary interest.
Financial Impact
No financial impact; initial ownership disclosure with no transaction.
Risk Factors
- No trading activity or change in position disclosed; filing is purely informational.
- OrbiMed's board representation could lead to insider trading restrictions.
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0000947871-26-001015 |
| Document: 0000947871-26-001015-index.html | 0000947871-26-001015 |
| Document: 0000947871-26-001015.txt | 0000947871-26-001015 |
Track record
15 reports on WWB
Filters
- Nov 16, 2026today Press Release Neutral 5/10 Entry $30.04 Now $30.04 +0.00% settles Dec 16
- Nov 13, 20263d ago Press Release Bullish 5/10 Entry $18.35 Now $30.04 +63.71% settles Dec 15
- Nov 13, 20263d ago EFFECT Neutral 6/10 Entry $28.50 Now $30.04 +5.40% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Viewing Entry $28.50 Now $30.04 +5.40% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $28.50 Now $30.04 +5.40% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $28.50 Now $30.04 +5.40% settles Dec 14
- Nov 12, 20264d ago Press Release Neutral 5/10 Entry $28.50 Now $30.04 +5.40% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 3/10 Entry $28.50 Now $30.04 +5.40% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $28.50 Now $30.04 +5.40% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $28.50 Now $30.04 +5.40% settles Dec 14
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers